abstract |
The present invention relates to oligommannosides produced by chemical synthesis, homologous to oligomannosides of the wall of an infectious or pathogenic organism, or a derivative thereof, such as a yeast, a fungus, a virus, a bacteria. The invention also relates to the preparation of said synthetic oligomannosides as well as their use for the diagnosis or prevention of infection. |